Powered by

Home Funding News Biotech Startup CrisprBits raises $3 Mn led by Spectrum Impact

Biotech Startup CrisprBits raises $3 Mn led by Spectrum Impact

CrisprBits will use the new funding to grow the commercial rollout of its PathCrisp diagnostic platform and expand test manufacturing for human health, food safety, and animal health. It is also building a CRISPR-based strain engineering platform, starting with improving biofuel production.

By Jitendra swami
New Update
Biotech Startup CrisprBits raises $3 Mn led by Spectrum Impact

CrisprBits Pvt Ltd, a biotech startup has raised USD 3 million in a Pre-Series A funding round from founders, angels and family offices, taking its valuation to $12 million. 

The round saw participation from Spectrum Impact, the family office of Rajendra Gogri, Chairman and Managing Director of Aarti Industries. Existing backers including Vijay Alreja Family Office (VJ Technologies Group) also participated, along with new investors from the promoter family of HBL Engineering.

Read also- SEBI Approves Fractal Analytics to Launch India’s First AI IPO

CrisprBits will use the new funding to grow the commercial rollout of its PathCrisp diagnostic platform and expand test manufacturing for human health, food safety, and animal health. The company is also building a CRISPR-based strain engineering platform, starting with improving biofuel production.

CEO Vijay Chandru emphasised the company’s mission-driven approach: “This funding round provides the fuel for our mission to Rewrite Biology and Reimagine the Planet. We are now positioned to launch in India and scale globally with high-quality, affordable solutions.”

Mirik Gogri of Spectrum Impact added: “CrisprBits is poised to create multidimensional impact—from diagnostics to biochemicals and biofuels. Their strategy converts powerful technology into immense commercial and societal value.”

Founded by Vijay Chandru, Sunil Arora, Rajeev Kohli, Bharat Jobanputra and Aditya Sarda, CrisprBits runs a 7,300 sq ft CRISPR research and prototype facility in Bengaluru. It has three platforms: PathCrisp for diagnostics, EdiCrisp for gene editing and strain engineering, and CurieCrisp for preclinical and rare disease therapies.

Advertisment

In the next six months, the company plans to take its CRISPR diagnostic products to global markets, including Africa and Latin America. It will also boost its operations by expanding infrastructure and production at its diagnostics facility. Additionally, CrisprBits aims to develop an AI-supported strain engineering platform for sustainability-focused applications.

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Latest Business and Startup NewsDiscover Funding Trends and Stories Shaping Indian Startups.

Startup Funding NewsYour Gateway to Every Funding Update.

Latest Startup NewsStay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.

Startup StoriesDiscover inspiring tales of startups overcoming challenges, and achieving success.